澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫藥生物股

634.950

-11.153-1.73%

漲家數：6

跌家數：15

平家數：22

市盈率：- -

高：645.436

開：638.323

低：632.715

收：646.103

成交量：8,234.08萬

成交額：1.08億

市值：902.65億

流通市值：870.71億

資料載入中...

英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者

CSL重大擴產計劃：大幅提升免疫球蛋白及白蛋白生產能力，惠及罕見病與重症患者

CSL達成協議：為美國藥品定價及特定232條款關税風險增添確定性

CSL有限公司：項目預計創造至少300個製藥製造業新崗位及約800個建築及相關崗位

CSL與美國政府達成協議降價藥品並助力本土製造投資

CSL有限公司：新協議助力降低療法價格，彰顯15億美元擴建伊利諾伊州美國產能計劃

特朗普政府將宣佈藥品定價協議

Proteomics International Laboratories — 本財務期間未支付、建議或宣派任何股息

莫納什試管嬰兒集團高層人事變動：兩位高管相繼宣佈退休計劃

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK7508/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"醫藥生物股","latestPrice":634.9499,"timestamp":1789106399475,"preClose":646.1032,"halted":0,"volume":82340846,"delay":0,"changeRate":-0.017262,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-11.15332,"latestTime":"09-11 16:00:00 AEST","open":638.3234,"high":645.43604,"low":632.7152,"amount":107748358.18,"amplitude":0.019689,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789084800000,1789106400000]],"turnoverRate":0.00323,"increases":7,"decrements":16,"flats":20,"marketCap":90265011743.75,"floatMarketCap":87070963229.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":645.43604,"amplitude":0.019689,"preClose":646.1032,"low":632.7152,"latestPrice":634.9499,"volume":82340846,"delay":0,"open":638.3234,"prevYearClose":644.3692,"prevWeekClose":666.366,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":666.366,"twentyDayClose":541.582,"sixtyDayClose":464.274,"secType":"PLATE","market":"AU","turnoverRate":0.00323,"marketCap":90265011743.75,"floatMarketCap":87070963229.625,"timestamp":1789106399475,"nameCN":"醫藥生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":15,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BIB","CSL.AU","LU2468319806.SGD","AMGN","BK4588","IBBQ","LU0320765992.SGD","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","BK4585","IE0002141913.USD","BK7511","BK4139","BK7501","LU2242646821.SGD","PJP","BK4566","IE0009355771.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2089984988.USD","BK4599","LU0122379950.USD","IBB","LU0868494617.USD","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","BK4533","BK7067","LU1983299246.USD","BK4534","BK7508","IE00B4R5TH58.HKD","TBXU","BK4581","PBE","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160995524","title":"CSL重大擴產計劃：大幅提升免疫球蛋白及白蛋白生產能力，惠及罕見病與重症患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1160995524","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160995524?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:27","pubTimestamp":1788204431,"startTime":"0","endTime":"0","summary":"CSL宣布了一项重大扩建项目，此举将显著增强其为罕见疾病及严重病症患者生产免疫球蛋白和白蛋白的能力。这一战略性举措不仅标志着公司在生物制药领域迈出的坚实一步，更意味着全球更多患者有望获得这些关键性治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181327820","title":"CSL達成協議：為美國藥品定價及特定232條款關税風險增添確定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1181327820","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181327820?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:25","pubTimestamp":1788204309,"startTime":"0","endTime":"0","summary":"CSL宣布，已通过相关协议为其在美国药品定价及部分第232条款关税方面的潜在风险敞口提供了更多确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","CSL.AU","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194972911","title":"CSL有限公司：項目預計創造至少300個製藥製造業新崗位及約800個建築及相關崗位","url":"https://stock-news.laohu8.com/highlight/detail?id=1194972911","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194972911?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:24","pubTimestamp":1788204248,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，其新项目将带来显著的就业增长。据估计，该项目将直接催生至少300个制药制造领域的全新工作岗位。与此同时，建筑业及相关配套行业也将迎来约800个就业机会。这一系列的岗位创造计划，无疑将为当地经济注入新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100124360","title":"CSL與美國政府達成協議 降價藥品並助力本土製造投資","url":"https://stock-news.laohu8.com/highlight/detail?id=1100124360","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100124360?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:23","pubTimestamp":1788204189,"startTime":"0","endTime":"0","summary":"生物技术巨头CSL已与美国政府签署新协议，旨在降低部分药品价格，同时加大对美国本土生产设施的投资力度。此举被视为制药行业响应政府控价压力、巩固供应链安全的最新动向之一。根据协议内容，该公司将在积极推进制造业扩张的同时，向市场提供更具竞争力的定价。业界分析指出，这一安排既反映了企业在政策环境下的策略调整，也凸显了医疗健康领域对成本控制与产能韧性的双重诉求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CSL.AU","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171032857","title":"CSL有限公司：新協議助力降低療法價格，彰顯15億美元擴建伊利諾伊州美國產能計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1171032857","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171032857?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:23","pubTimestamp":1788204189,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，一系列新达成的协议将支持其疗法产品价格的进一步下调，并充分体现了该公司斥资15亿美元用于扩建其位于伊利诺伊州的美国生产基地的宏伟蓝图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7508","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普  预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","LU1066053197.SGD","BK4585","ELIS","LU0114720955.EUR","CSL.AU","LU0466842654.USD","LU0868494617.USD","LU1145028129.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4139","LU2750360997.AUD","PJP","SG9999014880.SGD","TBXU","JDOC","LU0320765059.SGD","LU0289739699.SGD","LU2896262040.SGD","LU0323591593.USD","ELIL","LU0225283273.USD","LU0417517546.SGD","LLYX","LU0174119429.USD","IE00BK4W5L77.USD","TRUH","WDNA","LLY","LLYZ","LU0354030511.USD","LU1267930730.SGD","BK4568","SG9999003800.SGD","LU2089984988.USD","LU0097036916.USD","IE00BKDWB100.SGD","LU0306807586.USD","BK4588","LU2168564149.EUR","LU2265009873.SGD","LU2357305700.SGD","LU2237438978.USD","LU2361045086.USD","LU2552382215.SGD","MEDX","SG9999014906.USD","SG9999018857.SGD","LU1804176565.USD","CURE","LU0672654240.SGD","LU1868836591.USD","IE0004445239.USD","VHT","LU1814569148.SGD","SGXZ99366536.SGD","IYH","LU0109391861.USD","LU2168564222.USD","LU2271345857.HKD","LU2324357040.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","BK7511","LU2461242641.AUD","LU2471134796.USD","PFE","SG9999001176.USD","LU0170899867.USD","SG9999002224.SGD","LU0256863811.USD","LU0354030438.USD","LU2360106947.USD","LU0820561909.HKD","LU2361044865.SGD","LU1883839398.USD","LU0106261372.USD","LU0353189680.USD","LU0432979614.USD","LU2471134952.CNY","SG9999001176.SGD","LU2063271972.USD","IE00B4R5TH58.HKD","LU2023251221.USD","LU2552382058.USD","LU0266013472.USD","LU1894683348.USD","LU0096364046.USD","LU0320765992.SGD","LU0820561818.USD","LU1720051017.SGD","LU1868836757.USD","LU1057294990.SGD","CANC","LU0964807845.USD","BK4599","IBB","FTXH","LU0345770308.USD","LU0122379950.USD","LU0203202063.USD","LU1712237335.SGD","LU1979441026.SGD","LU2211815571.USD","LU0203201768.USD","LU0882574055.USD","PPH","BK4592","LU0345770993.USD","LU1868837300.USD","SG9999018865.SGD","SG9999015978.USD","LU2168564495.EUR","GB00BDT5M118.USD","IE00BN29S564.USD","LU0943347566.SGD","BK4566","LU0820562030.AUD","BK4007","LU0316494557.USD","BK7508","LU0640476718.USD","LU1629891620.HKD","LU1989771016.USD","LU2491050154.USD","BIB","LU2552382132.HKD","LU2746668461.USD","LU0471298777.SGD","SG9999015986.USD","LU2417539215.USD","SG9999002232.USD","LU0256863902.USD","LU2468319806.SGD","LU0079474960.USD","LU2471134879.HKD","AGNG","AMGN","LU0708995401.HKD","LU0823416689.USD","IE00B19Z3B42.SGD","IE00B7KXQ091.USD","LU0471298694.HKD","LU0061475181.USD","LU0306806265.USD","OZEM","IXJ","LU2237443895.HKD","SGXZ31699556.SGD","LU1093756325.SGD","LU2456880835.USD","RXL","IE00B1XK9C88.USD","LU1548497426.USD","LU2242652126.USD","IE00B19Z3581.USD","SG9999017495.SGD","LU2023250504.SGD","LU2756315664.SGD","LU0385154629.USD","LU0689472784.USD","LU2756315318.SGD","SGXZ51526630.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","IE00B3T34201.USD","LU1720051108.HKD","LU0094547139.USD","LU0238689110.USD","LU1571399168.USD","LU1323610961.USD","BK4581","LU1894683264.USD","LU1691799644.USD","LU0889565916.HKD","IHE","LU2089284900.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1366192091.USD","LU2237443978.SGD","SG9999014914.USD","04332","LU2491050071.SGD","SG9999015945.SGD","IE0002141913.USD","IE0009355771.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU2237443622.USD","LU1232071149.USD","LU1623119135.USD","PBE","BK4534","LU1551013425.SGD","SG9999011175.SGD","LU1069344957.HKD","BK4533","LU1917777945.USD","LU1983299246.USD","LU2462157665.USD","LU1280957306.USD","LU2602419157.SGD","TMED","LU2213496289.HKD","LU2111349929.HKD","LU0353189763.USD","IE00BJJMRX11.SGD","LU0787776722.HKD","LU0321505439.SGD","ILDR","SG9999015952.SGD","HRTS","SGXZ81514606.USD","FHLC","LLII","LU2168563687.JPY","LU0786609619.USD","XLV","IE00BK4W5M84.HKD","LU1551013342.USD","LU0133085943.USD","LU0683600562.USD","IONS","LU0456855351.SGD","LU2264538146.SGD","LU2087625088.SGD","LU2596442595.SGD","LU0823434740.USD","SG9999001440.SGD","IE00BFSS8Q28.SGD","LU2028103732.USD","IE0004445015.USD","LU0158827948.USD","LU0823434583.USD","IE00BJT1NW94.SGD","LU1988902786.USD","LU1868837136.USD","LU2236285917.USD","BK7501","LU0225284248.USD","IE00BFSS7M15.SGD","BK4550","GDOC","IBBQ","LU2108987350.USD","LU0985481810.HKD","BK4516","IE00BKPKM429.USD","LU0210536198.USD","LU0006306889.USD","LU2023250330.USD","LU2106854487.HKD","LU2237443465.HKD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1093756168.USD","LU0198837287.USD","IE00B775H168.HKD","LU0158827781.USD","IE00BJLML261.HKD","IE00B4JS1V06.HKD","LU1127390331.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1035775433.USD","IE000M9KFDE8.USD","LU2168564065.EUR","LU1291159041.SGD","LU2471134523.USD","LU0882574139.USD","LU2462591350.SGD","LU2237443382.USD","LU0234572021.USD","LU2361044949.HKD","LU2750360641.GBP","LU1066051498.USD","LU1023059063.AUD","THNR","LU0109394709.USD","LU1974910355.USD","LU2237443549.SGD","IE00B2B36J28.USD","LU1868836914.USD","MHIP","BBH","MEDI","LU2242646821.SGD","BK7067","LU2089283258.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151806519","title":"Proteomics International Laboratories — 本財務期間未支付、建議或宣派任何股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1151806519","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151806519?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:42","pubTimestamp":1788158524,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories——在当前财务期间，公司既未支付、亦未建议或宣派任何股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124411196","title":"莫納什試管嬰兒集團高層人事變動：兩位高管相繼宣佈退休計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1124411196","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124411196?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 06:32","pubTimestamp":1788129131,"startTime":"0","endTime":"0","summary":"莫纳什试管婴儿集团近日披露了一项重要人事变动安排。据悉，集团内部两位核心管理人员的退休时间表已正式敲定。两位高管的离任时间虽然相隔约两个月，但均已被明确列入集团的长期规划之中。对于这一系列变动，市场观察人士普遍认为，这反映了企业在领导层更替方面的有序布局。随着退休日期的临近，集团预计将逐步推进相关的交接工作，以确保管理层的平稳过渡和业务的持续稳定运行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MVF.AU","BK7113"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}